Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study.

Literature DB >> 1628175

Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study.

A J Peeters, B A Dijkmans, J G van der Schroeff.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Fumarates
fumaric acid

Year: 1992 PMID： 1628175 DOI： 10.1093/rheumatology/31.7.502

Source DB: PubMed Journal: Br J Rheumatol ISSN： 0263-7103

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

Review 1. Spondylarthropathies: options for combination therapy.

Authors: A M van Tubergen; R B Landewé; S van der Linden
Journal: Springer Semin Immunopathol Date: 2001

Review 2. Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.

Authors: A Atwan; J R Ingram; R Abbott; M J Kelson; T Pickles; A Bauer; V Piguet
Journal: Br J Dermatol Date: 2016-08-29 Impact factor: 9.302

3. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.

Authors: Josef S Smolen; Monika Schöls; Jürgen Braun; Maxime Dougados; Oliver FitzGerald; Dafna D Gladman; Arthur Kavanaugh; Robert Landewé; Philip Mease; Joachim Sieper; Tanja Stamm; Maarten de Wit; Daniel Aletaha; Xenofon Baraliakos; Neil Betteridge; Filip van den Bosch; Laura C Coates; Paul Emery; Lianne S Gensler; Laure Gossec; Philip Helliwell; Merryn Jongkees; Tore K Kvien; Robert D Inman; Iain B McInnes; Mara Maccarone; Pedro M Machado; Anna Molto; Alexis Ogdie; Denis Poddubnyy; Christopher Ritchlin; Martin Rudwaleit; Adrian Tanew; Bing Thio; Douglas Veale; Kurt de Vlam; Désirée van der Heijde
Journal: Ann Rheum Dis Date: 2017-07-06 Impact factor: 19.103

9. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2).

Authors: J L W Lambert; S Segaert; P D Ghislain; T Hillary; A Nikkels; F Willaert; J Lambert; R Speeckaert
Journal: J Eur Acad Dermatol Venereol Date: 2020-08-13 Impact factor: 6.166

9 in total

Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study.

Review 1. Spondylarthropathies: options for combination therapy.

Review 2. Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.

3. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.

4. Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.

5. Malassezia and Parkinson's Disease.

6. Fumaric acid esters in dermatology.

Review 7. Oral fumaric acid esters for psoriasis.

Review 8. Fumaric acid esters in the management of psoriasis.

9. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2).